A couple of excellent posts on this thread by you JTW.
You are one of the few who actually understand the superiority of Relenza over Tamiflu.
As someone with a bit of pharmacology in my background I have posted on it over the years, but have always maintained the dosage delivery system of Relenza was a problem compared to the simplicity of swallowing a Tamiflu capsule.
Marketing also a major major factor where Roche took a huge lead with Tamiflu...a bit like Windows swamped the superior Apple system.
What SHOULD be important right now is what works...and that is RELENZA
This will become apparent very shortly.
LANI still a year or 3 away, so for the current situation covering the rest of this calendar year and probably beyond, will not IMO have much influence of BTA price.
Cheers,
Bendigo
BTA Price at posting:
$1.38 Sentiment: ST Buy Disclosure: Held
